Literature DB >> 10588596

Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection.

Y Yamazaki1, K Kubo, A Takamizawa, H Yamamoto, T Honda, S Sone.   

Abstract

To predict the natural history of pulmonary Mycobacterium avium-intracellulare (MAI) infection with nodular bronchiectasis, we retrospectively evaluated clinical manifestations, laboratory data, and bronchoalveolar lavage fluid (BALF) findings in 57 patients. The patients received follow-up chest computed tomographic scans and testing for sputum bacteriology between intervals of at least 12 mo. They were divided into two groups after observation for 28 +/- 13 mo: deteriorated (n = 34) and not-deteriorated (n = 23). There were no patients with spontaneous improvement. At the start of observation, the mean age was greater in the deteriorated group (69 +/- 9 yr) than in the not-deteriorated group (57 +/- 9 yr). The mean body-mass index was lower in the deteriorated group (19.2 +/- 3.1 kg/m(2)) than in the not-deteriorated group (21.5 +/- 1.5 kg/m(2)). C-reactive protein, erythrocyte sedimentation rate, and carbohydrate antigen 19-9 were significantly elevated in the deteriorated group. The BALF findings of the deteriorated group showed that the neutrophil cell counts were significantly increased. Thirty-four of 57 patients with pulmonary MAI infection with nodular bronchiectasis had progressive clinical and/or radiographic disease. The older and thinner patients tended to become worse. Neutrophil-related inflammation associated with a decrease in CD4+ lymphocyte might reflect the progression of pulmonary MAI infection with nodular bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588596     DOI: 10.1164/ajrccm.160.6.9902019

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Steven A Cowman; Joseph Jacob; David M Hansell; Peter Kelleher; Robert Wilson; William O C Cookson; Miriam F Moffatt; Michael R Loebinger
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

2.  Serum levels of CA19-9 in patients with nonmalignant respiratory diseases.

Authors:  Takahide Kodama; Hiroaki Satoh; Hiroichi Ishikawa; Morio Ohtsuka
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.

Authors:  A Gomez; A Mve-Obiang; B Vray; W Rudnicka; I C Shamputa; F Portaels; W M Meyers; P A Fonteyne; L Realini
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

5.  Characterization of Immune Cells From the Lungs of Patients With Chronic Non-Tuberculous Mycobacteria or Pseudomonas aeruginosa Infection.

Authors:  Alan R Schenkel; John D Mitchell; Carlyne D Cool; Xiyuan Bai; Steve Groshong; Tilman Koelsch; Deepshikha Verma; Diane Ordway; Edward D Chan
Journal:  Immune Netw       Date:  2022-04-11       Impact factor: 5.851

6.  Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.

Authors:  Yun Su Sim; Hye Yun Park; Kyeongman Jeon; Gee Young Suh; O Jung Kwon; Won-Jung Koh
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

7.  Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases.

Authors:  Ji Young Shin; Su Jin Yoo; Bo Mi Park; Sung Su Jung; Ju Ock Kim; Jeong Eun Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-09-30

8.  Patients with MAC Lung Disease Have a Low Visceral Fat Area and Low Nutrient Intake.

Authors:  Kentaro Wakamatsu; Nobuhiko Nagata; Sanae Maki; Hisamitsu Omori; Hiroyuki Kumazoe; Kayoko Ueno; Yuko Matsunaga; Makiko Hara; Koji Takakura; Nagisa Fukumoto; Nobuhisa Ando; Mami Morishige; Takashi Akasaki; Ichiro Inoshima; Shinji Ise; Miiru Izumi; Masayuki Kawasaki
Journal:  Pulm Med       Date:  2015-11-29

9.  Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.

Authors:  Mina Gochi; Noboru Takayanagi; Tetsu Kanauchi; Takashi Ishiguro; Tsutomu Yanagisawa; Yutaka Sugita
Journal:  BMJ Open       Date:  2015-08-05       Impact factor: 2.692

10.  Normalization of Elevated CA 19-9 Level after Treatment in a Patient with the Nodular Bronchiectatic Form of Mycobacterium abscessus Lung Disease.

Authors:  Boksoon Chang; Seo Goo Han; Wooyoul Kim; Yousang Ko; Junwhi Song; Goohyeon Hong; Jung Seop Eom; Ji Hyun Lee; Byung Woo Jhun; Won-Jung Koh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.